In this episode John and Professor Shah open with why insulin alone has structural limitations in type 1 diabetes, work through how GLP-1 therapies act on the body, and then walk the trial evidence from the early exenatide and liraglutide studies to the more recent semaglutide and tirzepatide data
Understanding the BMI and eligibility question Not everyone qualifies for these medications through traditional prescribing channels
The active engagement in longevity goals varies by generation, though, which is important for technology and consumer products developers to understand
Recent data suggests that innate and adaptive immune systems contribute to low-grade inflammation and play a role in the development and progression of hypertension ( It has been found that DPP-4/CD26 participates in non-specific inflammation by predominantly regulating the activation and chemotaxis of mononuclear/macrophages, NK cells, and T cells
At Healthon, we have conducted extensive due diligence and partnered exclusively with reputable, fully compliant, US-based compounding pharmacies
